Global Biogeneric Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 06-Jun-2019
No. of pages: 110
Inquire Before Buying

Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.

Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company's return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.

The global Biogeneric Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biogeneric Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Biogeneric Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biogeneric Drugs in these regions.

This research report categorizes the global Biogeneric Drugs market by top players/brands, region, type and end user. This report also studies the global Biogeneric Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Sandoz International

- Teva pharmaceutical industries

- Mylan

- 3SBio

- Shanghai Fosun Pharmaceutical

- Tonghua Dongbao Pharmaceutical

- Biocon

- Reliance life sciences

- Probiomed

- Biosidus

- AMEGA Biotech

- Celltrion

- LG life Science

- Dong-A Pharmaceutical

Market size by Product

- Insulins

- Growth Hormones

- Monoclonal Antibodies

- Others

Market size by End User

- Hospital

- Clinics

- Research Centers

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Biogeneric Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Biogeneric Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Biogeneric Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Biogeneric Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biogeneric Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biogeneric Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Biogeneric Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Biogeneric Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biogeneric Drugs Market Size Growth Rate by Product
1.4.2 Insulins
1.4.3 Growth Hormones
1.4.4 Monoclonal Antibodies
1.4.5 Others
1.5 Market by End User
1.5.1 Global Biogeneric Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biogeneric Drugs Market Size
2.1.1 Global Biogeneric Drugs Revenue 2014-2025
2.1.2 Global Biogeneric Drugs Sales 2014-2025
2.2 Biogeneric Drugs Growth Rate by Regions
2.2.1 Global Biogeneric Drugs Sales by Regions
2.2.2 Global Biogeneric Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biogeneric Drugs Sales by Manufacturers
3.1.1 Biogeneric Drugs Sales by Manufacturers
3.1.2 Biogeneric Drugs Sales Market Share by Manufacturers
3.1.3 Global Biogeneric Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Biogeneric Drugs Revenue by Manufacturers
3.2.1 Biogeneric Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Biogeneric Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Biogeneric Drugs Price by Manufacturers
3.4 Biogeneric Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biogeneric Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biogeneric Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biogeneric Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biogeneric Drugs Sales by Product
4.2 Global Biogeneric Drugs Revenue by Product
4.3 Biogeneric Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biogeneric Drugs Breakdown Data by End User
6 North America
6.1 North America Biogeneric Drugs by Countries
6.1.1 North America Biogeneric Drugs Sales by Countries
6.1.2 North America Biogeneric Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biogeneric Drugs by Product
6.3 North America Biogeneric Drugs by End User
7 Europe
7.1 Europe Biogeneric Drugs by Countries
7.1.1 Europe Biogeneric Drugs Sales by Countries
7.1.2 Europe Biogeneric Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biogeneric Drugs by Product
7.3 Europe Biogeneric Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Biogeneric Drugs by Countries
8.1.1 Asia Pacific Biogeneric Drugs Sales by Countries
8.1.2 Asia Pacific Biogeneric Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biogeneric Drugs by Product
8.3 Asia Pacific Biogeneric Drugs by End User
9 Central & South America
9.1 Central & South America Biogeneric Drugs by Countries
9.1.1 Central & South America Biogeneric Drugs Sales by Countries
9.1.2 Central & South America Biogeneric Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biogeneric Drugs by Product
9.3 Central & South America Biogeneric Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Biogeneric Drugs by Countries
10.1.1 Middle East and Africa Biogeneric Drugs Sales by Countries
10.1.2 Middle East and Africa Biogeneric Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biogeneric Drugs by Product
10.3 Middle East and Africa Biogeneric Drugs by End User
11 Company Profiles
11.1 Sandoz International
11.1.1 Sandoz International Company Details
11.1.2 Company Business Overview
11.1.3 Sandoz International Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sandoz International Biogeneric Drugs Products Offered
11.1.5 Sandoz International Recent Development
11.2 Teva pharmaceutical industries
11.2.1 Teva pharmaceutical industries Company Details
11.2.2 Company Business Overview
11.2.3 Teva pharmaceutical industries Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Teva pharmaceutical industries Biogeneric Drugs Products Offered
11.2.5 Teva pharmaceutical industries Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Business Overview
11.3.3 Mylan Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Mylan Biogeneric Drugs Products Offered
11.3.5 Mylan Recent Development
11.4 3SBio
11.4.1 3SBio Company Details
11.4.2 Company Business Overview
11.4.3 3SBio Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 3SBio Biogeneric Drugs Products Offered
11.4.5 3SBio Recent Development
11.5 Shanghai Fosun Pharmaceutical
11.5.1 Shanghai Fosun Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Shanghai Fosun Pharmaceutical Biogeneric Drugs Products Offered
11.5.5 Shanghai Fosun Pharmaceutical Recent Development
11.6 Tonghua Dongbao Pharmaceutical
11.6.1 Tonghua Dongbao Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Products Offered
11.6.5 Tonghua Dongbao Pharmaceutical Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Company Business Overview
11.7.3 Biocon Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Biocon Biogeneric Drugs Products Offered
11.7.5 Biocon Recent Development
11.8 Reliance life sciences
11.8.1 Reliance life sciences Company Details
11.8.2 Company Business Overview
11.8.3 Reliance life sciences Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Reliance life sciences Biogeneric Drugs Products Offered
11.8.5 Reliance life sciences Recent Development
11.9 Probiomed
11.9.1 Probiomed Company Details
11.9.2 Company Business Overview
11.9.3 Probiomed Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Probiomed Biogeneric Drugs Products Offered
11.9.5 Probiomed Recent Development
11.10 Biosidus
11.10.1 Biosidus Company Details
11.10.2 Company Business Overview
11.10.3 Biosidus Biogeneric Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Biosidus Biogeneric Drugs Products Offered
11.10.5 Biosidus Recent Development
11.11 AMEGA Biotech
11.12 Celltrion
11.13 LG life Science
11.14 Dong-A Pharmaceutical
12 Future Forecast
12.1 Biogeneric Drugs Market Forecast by Regions
12.1.1 Global Biogeneric Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Biogeneric Drugs Revenue Forecast by Regions 2019-2025
12.2 Biogeneric Drugs Market Forecast by Product
12.2.1 Global Biogeneric Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Biogeneric Drugs Revenue Forecast by Product 2019-2025
12.3 Biogeneric Drugs Market Forecast by End User
12.4 North America Biogeneric Drugs Forecast
12.5 Europe Biogeneric Drugs Forecast
12.6 Asia Pacific Biogeneric Drugs Forecast
12.7 Central & South America Biogeneric Drugs Forecast
12.8 Middle East and Africa Biogeneric Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biogeneric Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Biogeneric Drugs Product Picture
Table Biogeneric Drugs Market Segments
Table Key Manufacturers Biogeneric Drugs Covered
Table Global Biogeneric Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Biogeneric Drugs Sales Market Share by Product 2014-2025
Figure Insulins Product Picture
Table Major Manufacturers of Insulins
Figure Growth Hormones Product Picture
Table Major Manufacturers of Growth Hormones
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Biogeneric Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospital
Figure Clinics
Figure Research Centers
Figure Biogeneric Drugs Report Years Considered
Figure Global Biogeneric Drugs Market Size 2014-2025 (Million US$)
Figure Global Biogeneric Drugs Sales 2014-2025 (K MT)
Table Global Biogeneric Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Biogeneric Drugs Sales by Regions 2014-2019 (K MT)
Table Global Biogeneric Drugs Sales Market Share by Regions 2014-2019
Figure Global Biogeneric Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Biogeneric Drugs Sales Market Share by Regions
Table Global Biogeneric Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Biogeneric Drugs Revenue Market Share by Regions 2014-2019
Figure Global Biogeneric Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biogeneric Drugs Revenue Market Share by Regions
Table Global Biogeneric Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Biogeneric Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Biogeneric Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biogeneric Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Biogeneric Drugs Revenue Share by Manufacturers (2014-2019)
Figure Biogeneric Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Biogeneric Drugs Price (2014-2019) (USD/MT)
Table Biogeneric Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biogeneric Drugs Product Type
Table Date of International Manufacturers Enter into Biogeneric Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table Global Biogeneric Drugs Sales Share by Product (2014-2019)
Figure Global Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure Global Biogeneric Drugs Sales Market Share by Product in 2018
Table Global Biogeneric Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Biogeneric Drugs Revenue Share by Product (2014-2019)
Figure Global Biogeneric Drugs Revenue Market Share by Product (2014-2019)
Figure Global Biogeneric Drugs Revenue Market Share by Product in 2018
Table Biogeneric Drugs Price by Product 2014-2019 (USD/MT)
Table Global Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table Global Biogeneric Drugs Sales Share by End User (2014-2019)
Figure Global Sales Biogeneric Drugs Market Share by End User (2014-2019)
Figure Global Sales Biogeneric Drugs Market Share by End User in 2018
Figure North America Biogeneric Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Biogeneric Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biogeneric Drugs Sales by Countries (2014-2019) (K MT)
Table North America Biogeneric Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biogeneric Drugs Sales Market Share by Countries
Table North America Biogeneric Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Biogeneric Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biogeneric Drugs Revenue Market Share by Countries
Figure United States Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Biogeneric Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table North America Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Biogeneric Drugs Market Share by Product
Table North America Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table North America Biogeneric Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Biogeneric Drugs Market Share by End User
Figure Europe Biogeneric Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Biogeneric Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biogeneric Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Biogeneric Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biogeneric Drugs Sales Market Share by Countries
Table Europe Biogeneric Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Biogeneric Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biogeneric Drugs Revenue Market Share by Countries
Figure Germany Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table Europe Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biogeneric Drugs Market Share by Product
Table Europe Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table Europe Biogeneric Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biogeneric Drugs Market Share by End User
Figure Asia Pacific Biogeneric Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Biogeneric Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biogeneric Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Biogeneric Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biogeneric Drugs Sales Market Share by Countries
Table Asia Pacific Biogeneric Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biogeneric Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biogeneric Drugs Revenue Market Share by Countries
Figure China Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biogeneric Drugs Market Share by Product
Table Asia Pacific Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Biogeneric Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biogeneric Drugs Market Share by End User
Figure Central & South America Biogeneric Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Biogeneric Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biogeneric Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Biogeneric Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biogeneric Drugs Sales Market Share by Countries
Table Central & South America Biogeneric Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biogeneric Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biogeneric Drugs Revenue Market Share by Countries
Figure Brazil Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biogeneric Drugs Market Share by Product
Table Central & South America Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Biogeneric Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biogeneric Drugs Market Share by End User
Figure Middle East and Africa Biogeneric Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Biogeneric Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biogeneric Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Biogeneric Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biogeneric Drugs Sales Market Share by Countries
Table Middle East and Africa Biogeneric Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biogeneric Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biogeneric Drugs Revenue Market Share by Countries
Figure GCC Countries Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biogeneric Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Biogeneric Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biogeneric Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Biogeneric Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biogeneric Drugs Market Share by Product
Table Middle East and Africa Biogeneric Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Biogeneric Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biogeneric Drugs Market Share by End User
Table Sandoz International Company Details
Table Sandoz International Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sandoz International Recent Development
Table Teva pharmaceutical industries Company Details
Table Teva pharmaceutical industries Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva pharmaceutical industries Recent Development
Table Mylan Company Details
Table Mylan Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table 3SBio Company Details
Table 3SBio Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table 3SBio Recent Development
Table Shanghai Fosun Pharmaceutical Company Details
Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Shanghai Fosun Pharmaceutical Recent Development
Table Tonghua Dongbao Pharmaceutical Company Details
Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Tonghua Dongbao Pharmaceutical Recent Development
Table Biocon Company Details
Table Biocon Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Reliance life sciences Company Details
Table Reliance life sciences Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Reliance life sciences Recent Development
Table Probiomed Company Details
Table Probiomed Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Probiomed Recent Development
Table Biosidus Company Details
Table Biosidus Biogeneric Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biosidus Recent Development
Table AMEGA Biotech Company Details
Table Celltrion Company Details
Table LG life Science Company Details
Table Dong-A Pharmaceutical Company Details
Table Global Biogeneric Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Biogeneric Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Biogeneric Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biogeneric Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Biogeneric Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Biogeneric Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Biogeneric Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biogeneric Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Biogeneric Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Biogeneric Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Biogeneric Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Biogeneric Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biogeneric Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Biogeneric Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biogeneric Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Biogeneric Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biogeneric Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Biogeneric Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biogeneric Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Biogeneric Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biogeneric Drugs Value Chain
Table Biogeneric Drugs Customers List
Table Biogeneric Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • (Post-pandemic Era) - Global Smoking Cessation Products Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Keyhole Limpet Hemocyanin (KLH) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 107
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Erythropoietin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 103
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Physiological Sea Water Nasal Spray Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 117
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Herbal Oil Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 114
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Excipients Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 104
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Cetrimide Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 107
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Smoking Cessation Products Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Nov-2020        Price: US 3650 Onwards        Pages: 107
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Keyhole Limpet Hemocyanin (KLH) Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Nov-2020        Price: US 3650 Onwards        Pages: 102
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs